Radiopaque liposomes: a promising new contrast material for computed tomography of the spleen

Area of Science:

• Biomedical imaging
• Nanotechnology
• Radiology

Background:

• Conventional contrast agents have limitations for spleen imaging.
• Liposomes offer potential for targeted drug delivery and enhanced imaging.
• Radiopaque materials can be incorporated into liposomes for CT contrast.

Purpose of the Study:

• To develop and evaluate radiopaque liposomes as a novel contrast agent for computed tomography (CT) of the spleen.
• To assess the biodistribution, CT enhancement, and toxicity of these liposomes.

Main Methods:

• Positively charged liposomes were formulated using lecithin, cholesterol, and stearylamine.
• Diatrizoic acid salts (Renografin) were encapsulated within the liposomes.
• Radiopaque liposomes were administered intravenously to rats and rabbits.
• Spleen iodine concentration and CT values were measured over 24 hours.
• Acute toxicity was assessed.

Main Results:

• The spleen exhibited the highest iodine concentration and was opacified on CT images post-administration.
• Contrast concentrations peaked at 30 minutes and declined over 24 hours.
• Spleen CT values in rats significantly increased with liposome injection compared to Renografin alone.
• Peak spleen CT numbers exceeded 100 HU with optimized liposome dosage.
• No acute toxicity was observed in the animal models.

Conclusions:

• Radiopaque liposomes demonstrate significant potential as effective spleen-specific CT contrast agents.
• The liposomal formulation enhances CT contrast in the spleen compared to conventional agents.
• Further investigation is warranted for clinical application in spleen imaging.